RxSight, Inc.
RXST
$12.62
-$0.47-3.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.80% | -11.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.80% | -11.24% | |||
| Cost of Revenue | -27.63% | -11.70% | |||
| Gross Profit | -3.82% | -11.08% | |||
| SG&A Expenses | -5.63% | 1.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.75% | -1.91% | |||
| Operating Income | 13.03% | -31.19% | |||
| Income Before Tax | 16.57% | -43.83% | |||
| Income Tax Expenses | -68.75% | 77.78% | |||
| Earnings from Continuing Operations | 16.71% | -43.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.71% | -43.91% | |||
| EBIT | 13.03% | -31.19% | |||
| EBITDA | 14.33% | -33.54% | |||
| EPS Basic | 17.18% | -43.08% | |||
| Normalized Basic EPS | 17.03% | -42.98% | |||
| EPS Diluted | 17.18% | -43.08% | |||
| Normalized Diluted EPS | 17.03% | -42.98% | |||
| Average Basic Shares Outstanding | 0.54% | 0.58% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||